TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Palette Life Sciences AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 (consolidated) |
| Turnover |
8,466
|
5,503
|
32,202 |
| Financial expenses |
1,511
|
3,565
|
3,630 |
| Earnings before taxes |
369
|
-30,769
|
-29,244 |
| EBITDA |
1,883
|
-30,251
|
-25,442 |
| Total assets |
61,520
|
79,341
|
33,627 |
| Current assets |
6,613
|
7,008
|
23,139 |
| Current liabilities |
23,963
|
40,845
|
21,513 |
| Equity capital |
37,557
|
38,496
|
-12,751 |
| - share capital |
269
|
278
|
277 |
| Employees (average) |
2
|
2
|
84 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 (consolidated) |
| Solvency |
61.0%
|
48.5%
|
-37.9% |
| Turnover per employee |
4,233
|
2,752
|
383 |
| Profit as a percentage of turnover |
4.4%
|
-559.1%
|
-90.8% |
| Return on assets (ROA) |
3.1%
|
-34.3%
|
-76.2% |
| Current ratio |
27.6%
|
17.2%
|
107.6% |
| Return on equity (ROE) |
1.0%
|
-79.9%
|
229.3% |
| Change turnover |
3,150
|
-26,792
|
15,149 |
| Change turnover % | 59% | 89% | |
| Chg. No. of employees |
0
|
-82
|
35 |
| Chg. No. of employees % | 0% | 71% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.